Requisite role for the dectin-1 β-glucan receptor in pulmonary defense against aspergillus fumigatus

Journal of Immunology

Volumn 182, Issue 8, 2009, Pages 4938-4946

  Werner, Jessica L ^a   Metz, Allison E ^a   Horn, Dawn ^a   Schoeb, Trenton R ^b   Hewitt, Matthew M ^c   Schwiebert, Lisa M ^c   Faro Trindade, Ines ^d   Brown, Gordon D ^d   Steele, Chad ^a  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON TETRACHLORIDE; CXCL1 CHEMOKINE; DECTIN 1; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; BETA GLUCAN RECEPTOR; BETA-GLUCAN RECEPTOR; IMMUNOGLOBULIN RECEPTOR; MEMBRANE PROTEIN; NERVE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPERGILLUS FUMIGATUS; CONTROLLED STUDY; CYTOKINE PRODUCTION; HOST RESISTANCE; INFECTION SENSITIVITY; LUNG ALVEOLUS MACROPHAGE; LUNG CLEARANCE; LUNG FUNCTION; LUNG PARENCHYMA; MACROPHAGE; MALE; MORTALITY; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SERODIAGNOSIS; ANIMAL; ASPERGILLOSIS; BIOSYNTHESIS; DISEASE PREDISPOSITION; GENETICS; IMMUNOLOGY; LUNG MYCOSIS; METABOLISM; PATHOLOGY; SURVIVAL RATE; TIME;

ANIMALS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; DISEASE SUSCEPTIBILITY; INTERLEUKIN-17; LUNG DISEASES, FUNGAL; MALE; MEMBRANE PROTEINS; MICE; NERVE TISSUE PROTEINS; NEUTROPHILS; RECEPTORS, IMMUNOLOGIC; SURVIVAL RATE; TIME FACTORS;

EID: 65249187409     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0804250     Document Type: Article

References (55)

1. Marr, K. A., T. Patterson, and D. Denning. 2002. Aspergillosis pathogenesis, clinical manifestations and therapy. Infect. Dis. Clin. North Am. 16: 875-894. (Pubitemid 35477517)
2. Barnes, P. D., and K. A. Marr. 2007. Risks, diagnosis and outcomes of invasive fungal infections in haematopoietic stem cell transplant recipients. Br. J. Haematol. 139: 519-531. (Pubitemid 350043811)
3. Fukuda, T., M. Boeckh, R. A. Carter, B. M. Sandmaier, M. B. Maris, D. G. Maloney, P. J. Martin, R. F. Storb, and K. A. Marr. 2003. Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning. Blood 102: 827-833. (Pubitemid 36917771)
4. Perlroth, J., B. Choi, and B. Spellberg. 2007. Nosocomial fungal infections: epidemiology, diagnosis and treatment. Med. Mycol. 45: 321-346. (Pubitemid 46839802)
5. Bulpa, P., A. Dive, and Y. Sibille. 2007. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur. Respir. J. 30: 782-800. (Pubitemid 351194841)
6. Muquim, A., S. Dial, and D. Menzies. 2005. Invasive aspergillosis in patients with chronic obstructive pulmonary diseases. Can. Respir. J. 12: 199-204. (Pubitemid 41065370)
7. Meersseman, W., K. Lagrou, J. Maertens, A. Wilmer, G. Hermans, S. Vanderschueren, I. Spriet, E. Verbeken, and E. Van Wijngaerden. 2008. Galactomannan in brochoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. Am. J. Respir. Crit. Care Med. 177: 27-34.
8. Schaffner, A., H. Douglas, and A. Braude. 1982. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus: observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes. J. Clin. Invest. 69: 617-631. (Pubitemid 12184959)
9. Chignard, M., V. Balloy, J. M. Sallenave, and M. Si-Tahar. 2007. Role of Toll-like receptors in lung innate defense against invasive aspergillosis: distinct impact in immunocompetent and immunocompromised hosts. Clin. Immunol. 124: 238-243. (Pubitemid 47247606)
10. Steele, C., R. R. Rapaka, A. Metz, S. M. Pop, D. L. Williams, S. Gordon, J. K. Kolls, and G. D. Brown. 2005. The β-glucan receptor dectin-1 recognizes specific morphologies of Aspergillus fumigatus. PLoS Pathog. 1:e.42: 323-334.
11. Gersuk, G. M., D. M. Underhill, and K. A. Marr. 2006. Dectin-1 and TLRs permit macrophages to distinguish between different Aspergillus fumigatus cellular states. J. Immunol. 176: 3717-3724.
12. Hohl, T. M., H. L. Van Epps, A. Rivera, L. A. Morgan, P. L. Chen, M. Feldmesser, and E. G. Pamer. 2005. Aspergillus fumigatus triggers inflammatory responses by stage-specific β-glucan display. PLoS Pathog. 1:e. 30: 232-240.
13. Brown, G. D., and S. Gordon. 2001. Immune recognition: a new receptor for β-glucans. Nature 413: 36-37.
14. Willment, J. A., A. S. J. Marshall, D. M. Reid, D. L. Williams, S. Y. C. Wong, S. Gordon, and G. D. Brown. 2005. The human β-glucan receptor is widely expressed and functionally equivalent to murine Dectin-1 on primary cells. Eur. J. Immunol. 35: 1539-1547.
15. Taylor, P. R., G. D. Brown, D. M. Reid, J. A. Willment, L. Martinez-Pomares, S. Gordon, and S. Y. Wong. 2002. The β-glucan receptor, dectin-1, is predominantly expressed on the surface of cells of the monocyte/macrophage and neutrophil lineages. J. Immunol. 169: 3876-3882.
16. Bellocchio, S., C. Montagnoli, S. Bozza, R. Gaziano, G. Rossi, S. S. Mambula, A. Vecchi, A. Mantovani, S. M. Levitz, and L. Romani. 2004. The contribution of Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo. J. Immunol. 172: 3059-3069. (Pubitemid 38263695)
17. Dubourdeau, M., R. Athman, V. Balloy, M. Huerre, M. Chignard, D. J. Philpott, J. P. Latge, and O. Ibrahim-Granet. 2006. Aspergillus fumigatus induces innate immune responses in alveolar macrophages through the MAPK pathway independently of TLR2 and TLR4. J. Immunol. 177: 3994-4001. (Pubitemid 44359932)
18. Bretz, C., G. Gersuk, S. Knoblaugh, N. Chaudhary, J. Randolph-Habecker, R. C. Hackman, J. Staab, and K. A. Marr. 2008. MyD88 signaling contributes to early pulmonary responses to Aspergillus fumigatus. Infect. Immun. 76: 952-958.
19. Taylor, P. R., S. V. Tsoni, J. A. Willment, K. M. Dennehy, M. Rosas, H. Findon, K. Haynes, C. Steele, M. Botto, S. Gordon, and G. D. Brown. 2007. Dectin-1 is required for β-glucan recognition and control of fungal infection. Nat. Immunol. 8: 31-38. (Pubitemid 46242356)
20. Mattila, P. E., A. E. Metz, R. R. Rapaka, L. D. Bauer, and C. Steele. 2008. Dectin-1 Fc targeting of Aspergillus fumigatus β-glucans augments innate defense against invasive pulmonary aspergillosis. Antimicrob. Agents Chemother. 52: 1171-1172.
21. Bowman, J. C., G. K. Abruzzo, J. W. Anderson, A. M. Flattery, C. J. Gill, V. B. Pikounis, D. M. Schmatz, P. A. Liberator, and C. M. Douglas. 2001. Quantitative PCR assay to measure Aspergillus fumigatus burden in a murine model of disseminated aspergillosis: demonstration of efficacy of caspofungin acetate. Antimicrob. Agents Chemother. 45: 3474-3481.
22. Lundblad, L. K., J. Thompson-Figueroa, T. Leclair, M. J. Sullivan, M. E. Poynter, C. G. Irvin, and J. H. Bates. 2005. Tumor necrosis factor-β overexpression in lung disease: a single cause behind a complex phenotype. Am. J. Respir. Crit. Care Med. 171: 1363-1370.
23. Zelante, T., A. De Luca, T. Bonifazi, C. Montagnoli, S. Bozza, S. Moretti, M. L. Belladonna, C. Vacca, C. Conte, P. Mosci, et al. 2007. IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur. J. Immunol. 37: 2695-2706. (Pubitemid 47578289)
24. Sheppard, D. C., K. A. Marr, D. N. Fredricks, L. Y. Chiang, T. Doedt, and S. G. Filler. 2006. Comparison of three methodologies for the determination of pulmonary fungal burden in experimental murine aspergillosis. Clin. Micro Infect. 12: 376-380.
25. Pollock, J. D., D. A. Williams, M. A. Gifford, L. L. Li, X. Du, J. Fisherman, S. H. Orkin, C. M. Doerschuk, and M. C. Dinauer. 1995. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat. Genet. 9: 202-209.
26. Morgenstern, D. E., M. A. Gifford, L. L. Li, C. M. Doerschuk, and M. C. Dinauer. 1997. Absence of respiratory burst in X-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to Aspergillus fumigatus. J. Exp. Med. 185: 207-218.
27. Bonnett, C. R., E. J. Cornish, A. G. Harmsen, and J. B. Burritt. 2006. Early neutrophil recruitment and aggregation in the murine lung inhibit germination of Aspergillus fumigatus conidia. Infect. Immun. 74: 6528-6539.
28. Mehrad, B., R. M. Strieter, T. A. Moore, W. C. Tsai, S. A. Lira, and T. J. Standiford. 1999. CXC chemokine receptor-2 ligands are necessary components of neutrophil-mediated host defense in invasive pulmonary aspergillosis. J. Immunol. 163: 6086-6094.
29. Mehrad, B., T. A. Moore, and T. Standiford. 2000. Macrophage inflammatory protein-1α is a critical mediator of host defense against invasive pulmonary aspergillosis in neutropenic hosts. J. Immunol. 165: 962-968. (Pubitemid 30484765)
30. Segal, B. H. 2007. Role of macrophages in host defense against aspergillosis and strategies for immune augmentation. Oncologist 12(Suppl. 2): 7-13.
31. Hara, H., C. Ishihara, A. Takeuchi, T. Imanishi, L. Xue, S. W. Morris, M. Inui, T. Takai, A. Shibuya, S. Saijo, et al. 2007. The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptors. Nat. Immunol. 8: 619-629. (Pubitemid 46785126)
32. Gross, O., A. Gewies, K. Finger, M. Schafer, T. Sparwasser, C. Peschel, I. Forster, and J. Ruland. 2006. Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity. Nature 442: 651-656. (Pubitemid 44215314)
33. LeibundGut-Landmann, S., O. Grob, M. J. Robinson, F. Osorio, E. C. Slack, S. V. Tsoni, E. Schweighoffer, V. Tybulewicz, G. D. Brown, J. Ruland, and C. Reis E Sousa. 2007. Syk- and Card9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat. Immunol. 8: 630-638. (Pubitemid 46785127)
34. Romani, L., F. Fallarino, A. De Luca, C. Montagnoli, C. D'Angelo, T. Zelante, C. Vacca, F. Bistoni, M. C. Fioretti, U. Grohmann, et al. 2008. Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature 451: 211-215.
35. Happel, K. I., P. J. Dubin, M. Zheng, N. Ghilardi, C. Lockhart, L. J. Quinton, A. R. Odden, J. E. Shelliot, G. J. Bagby, S. Nelson, and J. K. Kolls. 2005. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J. Exp. Med. 202: 761-769.
36. Saijo, S., N. Fugikado, T. Furuta, S. H. Chung, H. Kotaki, K. Seki, K. Sudo, S. Akira, Y. Adachi, N. Ohno, et al. 2007. Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans. Nat. Immunol. 8: 39-46. (Pubitemid 46242357)
37. Nakamura, K., T. Kinjo, S. Saijo, A. Miyazato, Y. Adachi, N. Ohno, J. Fujita, M. Kaku, Y. Iwakura, and K. Kawakami. 2007. Dectin-1 is not required for the host defense to Cryptococcus neoformans. Microbiol. Immunol. 51: 1115-1119. (Pubitemid 350145861)
38. Matsumoto, Y., S. Matsuda, and T. Tegoshi. 1989. Yeast glucan in the cyst wall of Pneumocystis carinii. J. Protozool. 36: 21s-22s.
39. De Stefano, J. A., M. T. Cushion, V. Puvanesarajah, and P. D. Walzer. 1990. Analysis of Pneumocystis carinii cyst wall. II. Sugar composition. J. Protozool. 37: 436-441.
40. Bellocchio, S., S. Moretti, K. Perruccio, F. Fallarino, S. Bozza, C. Montagnoli, P. Mosci, G. B. Lipford, L. Pitzurra, and L. Romani. 2004. TLR2 govern neutrophil activity in aspergillosis. J. Immunol. 173: 7406-7415. (Pubitemid 39628180)
41. Garlanda, C., E. Hirsch, S. Bozza, A. Salustri, M. De Acetis, R. Nota, A. Maccagno, F. Riva, B. Bottazzi, G. Peri, et al. 2002. Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response. Nature 420: 182-186.
42. Trullas, J. C., C. Cervera, N. Benito, J. P. de la Bellacasa, C. Agusti, M. Rovira, A. Mas, M. Navasa, F. Cofan, M. J. Ricart, et al. 2005. Invasive pulmonary aspergillosis in solid organ and bone marrow transplant recipients. Transplant. Proc. 37: 4091-4093.
43. Shaukat, A., F. Bakri, P. Young, T. Hanh, D. Ball, M. R. Baer, M. Wetzler, J. L. Slack, P. Loud, M. Czuczman, et al. 2005. Invasive filamentous fungal infections in allogeneic hematopoietic stem cell transplant recipients after recovery from neutropenia: clinical, radiologic, and pathologic characteristics. Mycopathologia 159: 181-188. (Pubitemid 40633920)
44. Mehrad, B., R. M. Strieter, and T. J. Standiford. 1999. Role of TNF-α in pulmonary host defense in murine invasive aspergillosis. J. Immunol. 162: 1633-1640. (Pubitemid 29307039)
45. Gao, J. L., T. A. Wynn, Y. Chang, E. J. Lee, H. E. Broxmeyer, S. Cooper, H. L. Tiffany, H. Westphal, J. Kwon-Chung, and P. M. Murphy. 1997. Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J. Exp. Med. 185: 1959-1968.
46. Thompson, G. R., and T. F. Patterson. 2008. Pulmonary aspergillosis. Semin. Respir. Crit. Care Med. 29: 103-110.
47. Aratani, Y., F. Kura, H. Watanabe, H. Akagawa, Y. Takano, K. Suzuki, N. Maeda, and H. Koyama. 2000. Differential host susceptibility to pulmonary infections with bacteria and fungi in mice deficient in myeloperoxidase. J. Infect. Dis. 182: 1276-1279.
48. Zarember, K. A., J. A. Sugui, Y. C. Chang, K. J. Kwon-Chung, and J. I. Gallin. 2007. Human polymorphonuclear leukocytes inhibit Aspergillus fumigatus conidial growth by lactoferrin-mediated iron depletion. J. Immunol. 178: 6367-6373.
49. Forehand, J. R., and R. B. Johnston. 1994. Chronic granulomatous disease: newly defined molecular abnormalities explain disease variability and normal phagocyte physiology. Curr. Opin. Pediatr. 6: 668-675.
50. Pham, C. T. 2006. Neutrophil serine proteases: specific regulators of inflammation. Nat. Rev. Immunol. 6: 541-550.
51. Bozza, S., T. Zelante, S. Moretti, P. Bonifazi, A. DeLuca, C. D'Angelo, G. Giovannini, C. Garlanda, L. Boon, F. Bistoni, et al. 2008. Lack of Toll IL-1R8 exacerbates Th17 cell responses in fungal infection. J. Immunol. 180: 4022-4031.
52. Aujla, S. J., P. J. Dubin, and J. K. Kolls. 2007. Th17 cells and mucosal host defense. Semin. Immunol. 19: 377-382.
53. Ramaprakash, H., T. Ito, T. J. Standiford, S. L. Kunkel, and C. M. Hogaboam. 2009. TLR9 modulates immune responses to Aspergillus fumigatus conidia in immunodeficient and allergic mice. Infect. Immun. 77: 108-119.
54. H17 cell differentiation in subjects with autosomal dominant hyper- IgE syndrome. Nature 452: 773-776.
55. Freeman, A. F., D. E. Kleiner, H. Nadiminti, J. Davis, M. Quezado, V. Anderson, J. M. Puck, and S. M. Holland. 2007. Causes of death in hyper-IgE syndrome. J. Allergy Clin. Immunol. 119: 1234-1240.